Enhanced sympathetic neurotransduction in the superior mesenteric artery in a rat model of heart failure: role of noradrenaline and ATP

Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H563-H574. doi: 10.1152/ajpheart.00444.2020. Epub 2020 Nov 8.

Abstract

Heart failure (HF) is associated with neurohumoral activation, which in turn leads to an increased peripheral resistance. In mesenteric vasculature, perivascular innervation plays relevant role maintaining vascular tonus and resistance. Therefore, we aimed to determine the possible alterations in superior mesenteric artery (SMA) perivascular innervation function in HF rats. HF was induced by coronary artery occlusion in male Wistar rats, and sham-operated (SO) rats were used as controls. After 12 wk, a greater vasoconstrictor response to electrical field stimulation (EFS) was observed in endothelium-intact and endothelium-denuded SMA of HF rats. Alpha-adrenoceptor antagonist phentolamine diminished this response in a higher magnitude in HF than in SO animals. However, the noradrenaline (NA) reuptake inhibitor desipramine increased EFS-induced vasoconstriction more in segments from HF rats. Besides, EFS-induced NA release was greater in HF animals, due to a higher tyrosine hydroxylase expression and activity. P2 purinoceptor antagonist suramin reduced EFS-induced vasoconstriction only in segments from SO rats, and adenosine 5'-triphosphate (ATP) release was lower in HF than in SO. Moreover, nitric oxide (NO) synthase inhibitor Nω-nitro-L-arginine methyl ester (L-NAME) enhanced EFS-induced vasoconstriction in a similar extent in both groups. HF was not associated with changes in EFS-induced NO release or the vasodilator response to NO donor sodium nitroprusside. In conclusion, HF postmyocardial infarction enhanced noradrenergic function and diminished purinergic cotransmission in SMA and did not change nitrergic innervation. The net effect was an increased sympathetic participation on the EFS-induced vasoconstriction that could help to understand the neurotransduction involved on the control of vascular tonus in HF.NEW & NOTEWORTHY This study reinforces the pivotal role of noradrenergic innervation in the regulation of mesenteric vascular tone in a rat model of heart failure. Moreover, our results highlight the counteracting role of ATP and NA reuptake, and help to understand the signaling pathways involved on the control of vascular tonus and resistance in heart failure postmyocardial infarction.

Keywords: ATP; heart failure; noradrenaline; perivascular innervation; purinergic cotransmission; sympathetic innervation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / metabolism*
  • Adrenergic Uptake Inhibitors / pharmacology
  • Adrenergic alpha-Antagonists / pharmacology
  • Animals
  • Desipramine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Heart Failure / metabolism*
  • Heart Failure / physiopathology
  • Male
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / metabolism
  • Mesenteric Arteries / physiopathology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Donors / pharmacology
  • Nitroprusside / pharmacology
  • Norepinephrine / metabolism*
  • Phentolamine / pharmacology
  • Purinergic P2 Receptor Antagonists / pharmacology
  • Rats
  • Rats, Wistar
  • Suramin / pharmacology
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiopathology
  • Synaptic Transmission*
  • Vasoconstriction

Substances

  • Adrenergic Uptake Inhibitors
  • Adrenergic alpha-Antagonists
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Purinergic P2 Receptor Antagonists
  • Nitroprusside
  • Suramin
  • Adenosine Triphosphate
  • Desipramine
  • NG-Nitroarginine Methyl Ester
  • Norepinephrine
  • Phentolamine